Conference
IMCAS ASIA 2023
Cellenis @ IMCAS ASIA 2023 Our cellenis team will be attending the exciting Aesthetic & Dermatology congress taking place from June 9 – 11 at
Cellenis @ IMCAS ASIA 2023 Our cellenis team will be attending the exciting Aesthetic & Dermatology congress taking place from June 9 – 11 at
Tropocells at EFORT 2023 Discover the TROPOCELLS OrthoBiologics portfolio @ EFORT 2023. Meet us at the 24th European Federation of National Associations of Orthopedics and Traumatology
Tropocells® at AAOS 2023 Tropcells® PRP line of products will be presented and showcased at the Annual Meeting of the American Academy of Orthopedic Surgeons
You are welcome to visit us at booth #F4 and meet the Cellenis® European team at AMWC 2023. We will be happy to present and
You are welcome to visit us at booth #N152 and meet the Cellenis® PRP European team at the IMCAS World Congress 2023. We will be
Regen Lab SA (Regenlab) has failed to pay legal costs ordered by the UK High Court after revocation of its PRP patent for lack of novelty and inventive step. Regenlab is exposed to enforcement procedures which may limit its ability to provide products in the marketplace…
Estar Medical has been successful in revoking Regenlab’s original PRP patent in the European Patent Office (EPO) opposition proceedings. This ruling follows a recent judgment by the UK High Court which also found the Regenlab PRP patent invalid for lack of novelty and inventive step…
The UK Court refused to grant Regenlab permission to appeal the finding that its European PRP patent is invalid…
15, Hamerkava St., Holon
5885111, Israel
Tel: +972-3-5596414
Fax: +972-3-5596424
Email: sales@estar-medical.com
The products shown in this webpage are not cleared by the U.S. FDA for sale in the USA.
© 2023 All rights reserved to Estar Technologies Ltd. | Site by Shiran Waldman & Arctica